MSCs are able to stimulate tumor growth, increase angiogenesis, and favor metastasis development mainly through the release of activating factors such as cytokines and growth factors including IL-6 [167] and GDF15 in hematological malignancies [168]. Here, IL6 is linked to neoplasm.